BRCA1 and breast carcinoma: HCC1937, a TNBC line derived from a 24-year-old woman with a family history of breast cancer and a germline mutation in BRCA1 [96,97], was sensitive to pilocarpine, RITA, TG101348, and tremorine, and resistant to AS703026, dasatinib, midostaurin, nilotinib, PD0325901, PD198306, and PD98059.